GSK’s new asthma drug Relvar Ellipta has shown itself to be superior to existing treatments in a major real world trial, the Salford Lung Study (SLS). Developed with US respiratory specialist ...

MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

Short-acting beta-agonists (SABAs) are a class of bronchodilators used to treat asthma symptoms quickly. They’re primarily inhaled via a rescue inhaler or a nebulizer. SABA medications work by ...

Over-the-counter (OTC) inhalers are not approved for treating chronic obstructive pulmonary disease (COPD). Aside from the fact that they are ineffective for COPD, these inhalers can pose risks ...

The first-in class medicine for severe asthma co-developed by AstraZeneca and Amgen is poised for accelerated approval after the US Food and Drug Administration granted it a breakthrough designation.

Additional data from the MDNA11 ABILITY-1 trial to be presented at the Annual MeetingPre-clinical data on Medicenna’s first-in-class Masked and ...

Severe asthma is a chronic respiratory condition in which your symptoms are more intense and difficult to control than mild-to-moderate cases. Treatments include corticosteroids, biologics, and more.

“This achievement reflects both the strong interest in amylin agonists from the clinical community and ... About petrelintide Petrelintide is a long-acting amylin analog suitable for once-weekly ...

A NURSE suffered a fatal cardiac arrest after being prescribed a fatal combination of three common drugs. Her sudden passing prompted an urgent warning to doctors dishing out the medications, over ...